Phase 1 clinical trials
In Dicot's first clinical trial, LIB-01 is tested in healthy participants. The trial primarily aims to investigate the safety of LIB-01 in humans. At the same time, the drug uptake, metabolism and excretion will be studied. A Phase 1 trial usually takes approximately 1 year to complete until the final study report can be completed.